Félix Rueda

1.3k total citations
36 papers, 1.1k citations indexed

About

Félix Rueda is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Félix Rueda has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Félix Rueda's work include Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (6 papers) and Immune Cell Function and Interaction (6 papers). Félix Rueda is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (6 papers) and Immune Cell Function and Interaction (6 papers). Félix Rueda collaborates with scholars based in Spain, Netherlands and South Africa. Félix Rueda's co-authors include Luis J. Cruz, Joan Carles Domingo, Ferry Ossendorp, Clemens W.G.M. Löwik, Fernando Alberício, Rodney Alexander Rosalia, Jan Willem Kleinovink, Paul J. Tacken, Carl G. Figdor and Begoña Cordobilla and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Félix Rueda

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Félix Rueda Spain 17 568 472 239 209 129 36 1.1k
Roberta Carosio Italy 19 567 1.0× 402 0.9× 72 0.3× 244 1.2× 83 0.6× 36 1.2k
Fazel Shokri Iran 16 320 0.6× 518 1.1× 119 0.5× 273 1.3× 114 0.9× 71 1.1k
Feiran Cheng China 10 493 0.9× 729 1.5× 196 0.8× 321 1.5× 54 0.4× 17 1.4k
Kaiyong Yang China 22 1.3k 2.4× 564 1.2× 203 0.8× 305 1.5× 67 0.5× 37 2.3k
Tianxia Lan China 15 461 0.8× 643 1.4× 134 0.6× 391 1.9× 50 0.4× 23 1.5k
Niranjan B. Pandey United States 22 438 0.8× 651 1.4× 108 0.5× 550 2.6× 70 0.5× 34 1.5k
Piotr Swiderski United States 27 593 1.0× 2.0k 4.2× 187 0.8× 473 2.3× 75 0.6× 49 2.7k
Heather J. Bax United Kingdom 19 448 0.8× 403 0.9× 123 0.5× 231 1.1× 117 0.9× 39 1.2k
Jaclyn Milton United States 8 263 0.5× 473 1.0× 92 0.4× 46 0.2× 119 0.9× 10 867

Countries citing papers authored by Félix Rueda

Since Specialization
Citations

This map shows the geographic impact of Félix Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Félix Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Félix Rueda more than expected).

Fields of papers citing papers by Félix Rueda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Félix Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Félix Rueda. The network helps show where Félix Rueda may publish in the future.

Co-authorship network of co-authors of Félix Rueda

This figure shows the co-authorship network connecting the top 25 collaborators of Félix Rueda. A scholar is included among the top collaborators of Félix Rueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Félix Rueda. Félix Rueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rueda, Félix, et al.. (2019). A transient hyperammonemia in a neonatal patient due to a toxic dose with valproic acid. 21(4). 227–229.
2.
Rueda, Félix, et al.. (2019). A case report of dalbavancin Off-Label use in a 4 years old pediatric patient. 21(2). 112–115. 1 indexed citations
3.
Rueda, Félix, et al.. (2019). Review and case report: Hepatoid adenocarcinoma of the lung treated with nivolumab metastatizing to the skin. 21(3). 149–154.
4.
Rueda, Félix, Christina Eich, Begoña Cordobilla, et al.. (2017). Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccines. Immunobiology. 222(11). 989–997. 37 indexed citations
5.
Rueda, Félix & Luis J. Cruz. (2017). Targeting the Brain with Nanomedicine. Current Pharmaceutical Design. 23(13). 1879–1896. 10 indexed citations
6.
Silva, Candido G. Da, Félix Rueda, Clemens W.G.M. Löwik, Ferry Ossendorp, & Luis J. Cruz. (2016). Combinatorial prospects of nano-targeted chemoimmunotherapy. Biomaterials. 83. 308–320. 108 indexed citations
7.
Rueda, Félix, et al.. (2015). Características clínico-epidemiológicas de pacientes hospitalizados en tratamiento con antibióticos de uso restringido en un hospital de segundo nivel: análisis de prescripción. Institutional Repository of the University of Granada (University of Granada). 56(3). 161–164.
8.
Rueda, Félix, et al.. (2015). Reacción de hipersensibilidad a carboplatino no reversible mediante protocolo de desensibilización. Institutional Repository of the University of Granada (University of Granada). 56(1). 32–35.
9.
Cruz, Luis J., Rodney Alexander Rosalia, Jan Willem Kleinovink, et al.. (2014). Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study. Journal of Controlled Release. 192. 209–218. 191 indexed citations
10.
Cruz, Luis J., Paul J. Tacken, Félix Rueda, et al.. (2012). Targeting Nanoparticles to Dendritic Cells for Immunotherapy. Methods in enzymology on CD-ROM/Methods in enzymology. 509. 143–163. 107 indexed citations
11.
Rueda, Félix, Joan Carles Domingo, & Núria Mach. (2011). Efectos de los ácidos grasos omega 3 y otros suplementos alimenticios en procesos patológicos relacionados con la tercera edad. Revista Española de Nutrición Humana y Dietética. 15(1). 20–29. 5 indexed citations
12.
Rueda, Félix, B Amill, Sergio Querol, et al.. (2002). Combined isolation of CD34+ progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods. Transfusion. 42(7). 912–920. 4 indexed citations
13.
González‐Barca, Eva, A Grañena, A. Fernández‐Sevilla, et al.. (1999). Low‐dose subcutaneous interleukin‐2 in patients with minimal residual lymphoid neoplasm disease. European Journal Of Haematology. 62(4). 231–238. 7 indexed citations
14.
Ferrá, Christelle, Sílvia de Sanjosé, David Gallardo, et al.. (1998). IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.. PubMed. 83(12). 1082–7. 32 indexed citations
15.
Pardo, Núria, Francesc Martí, Gloria Fraga, et al.. (1996). High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: Pilot study. Medical and Pediatric Oncology. 27(6). 534–539. 16 indexed citations
16.
Rueda, Félix, Francesc Martí, Núria Pardo, et al.. (1996). Interleukin-2 in Neuroblastoma: Clinical Perspectives Based on Biological Studies. Cancer Biotherapy and Radiopharmaceuticals. 11(5). 303–308. 8 indexed citations
17.
Martí, Francesc, et al.. (1995). Higher cytotoxic activity and increased levels of IL‐1β, IL‐6, and TNF‐α in patients undergoing cardiopulmonary bypass. American Journal of Hematology. 49(3). 237–239. 15 indexed citations
18.
Rueda, Félix, et al.. (1991). Abnormal Levels of Platelet-Specific Proteins and Mitogenic Activity in Myeloproliferative Disease. Acta Haematologica. 85(1). 12–15. 10 indexed citations
19.
Rueda, Félix, et al.. (1990). Different Lymphocyte Activity in Patients with Polycythaemia vera Versus Secondary Polycythaemia and Healthy Blood Donors. Acta Haematologica. 83(1). 31–34. 3 indexed citations
20.
Rueda, Félix, et al.. (1989). Artefactual low lymphocyte activity caused by platelet contamination in the mononuclear cell preparations. American Journal of Hematology. 31(2). 126–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026